The heavy lifting for the pharmaceutical industry to comply with the November 2023 DSCSA go-live date is still ongoing. Thankfully much (but not all) of what is required is now well defined and available for the industry to implement. One of these items that is finalized is ensuring that the required data exchange through the supply chain is only done with trusted, authorized, and registered trading partners. With so many touchpoints, it is essential to confirm that only trusted entities are involved in the exchange of prescription drugs.